Forget 2025: These 2 Growth Stocks Could Soar in 2026

Group 1: DraftKings - DraftKings shares lost 8% in value last year and closed 35% below their 2025 peak due to slowing growth and competition from platforms like Kalshi and Polymarket [4] - Concerns about competition disrupting DraftKings' growth are considered overblown, as the brand's recognition and partnerships provide significant marketing advantages [5][6] - DraftKings is diversifying its revenue streams, with casino-style gaming accounting for nearly half of its revenue, which may remind investors of its growth potential [7] Group 2: Recursion Pharmaceuticals - Recursion Pharmaceuticals experienced a 44% pullback last year, but 2026 could be a pivotal year for the company [8] - The company has developed an AI-powered drug discovery platform, Recursion OS, which can analyze 65 petabytes of data to predict drug performance [9]